Indoco’s revenues grow at 43%, EBIDTA jumps 78 % in Q1FY22: During the first quarter of FY 2021-22, revenues of Indoco Remedies grew by 42.9 % at Rs. 381.2 crores, as against Rs. 266.8 crores, same quarter last year. EBIDTA to net sales for the quarter is 22.8 % at Rs. 86.8 crores, compared to 18.3 % at Rs. 48.9 crores, same quarter last year. For the quarter, the Profit After Tax to net sales is 10.4 % at Rs. 39.6 crores, compared to 6.5 % at Rs.17.2 crores, same quarter last year. Commenting on the first quarter FY22 results, Aditi Panandikar, Managing Director, Indoco Remedies Ltd., said, “Our India & International Businesses have shown a robust growth this quarter. We have optimised the opportunities presented by this very dynamic business environment as well as effectively adapted to the challenges thus presented”. Result PDF